-
公开(公告)号:US20220348903A1
公开(公告)日:2022-11-03
申请号:US17642582
申请日:2020-09-11
Applicant: THE UNIVERSITY OF CHICAGO
Inventor: Rama Ranganathan , Andrew Ferguson
Abstract: A method and apparatus are provided for designing sequence-defined biomolecules, such as proteins using a data-driven, evolution-based process. To design proteins, an iterative method founded on a combination of an unsupervised sequence-based model with a supervised functionality-based model can select candidate amino acid sequences that are likely to have a desired functionality. Feedback from measuring the candidate proteins using a high-throughput gene-synthesis and a protein screening process is used to refine and improve the models guiding the candidate selection to the most promising regions of the very large amino acid sequence search space.
-
公开(公告)号:US20220347186A1
公开(公告)日:2022-11-03
申请号:US17763445
申请日:2020-09-25
Applicant: THE UNIVERSITY OF CHICAGO
Inventor: Lucy A. Godley , John Z. Cao , Amittha Wickrema
IPC: A61K31/55 , A61P7/06 , A61K31/444 , A61K31/17 , A61K31/4439
Abstract: This disclosure relates to methods and compositions for treating sickle cell anemia or thalassemia in a subject in need thereof. As described herein in a first aspect the present disclosure provides a method of treating an inherited blood disorder in a subject In need thereof comprising administering to the subject a therapeutically effective amount of a bromodomain and extra-terminal motif (BET) protein inhibitor.
-
73.
公开(公告)号:US11478799B2
公开(公告)日:2022-10-25
申请号:US15926985
申请日:2018-03-20
Applicant: The University of Chicago
Inventor: Rustem F. Ismagilov , Joshua David Tice , Cory John Gerdts , Bo Zheng
IPC: B01L3/00 , B01J19/00 , B82Y30/00 , G01N35/08 , B01F25/433 , B01F33/302 , G01N1/28 , B01D9/00 , C07K14/43 , C12N9/36 , C30B7/14 , C30B29/54 , C30B29/58 , B01J14/00 , C12Q1/6806
Abstract: The present invention provides microfabricated substrates and methods of conducting reactions within these substrates. The reactions occur in plugs transported in the flow of a carrier-fluid.
-
公开(公告)号:US11468559B2
公开(公告)日:2022-10-11
申请号:US16607218
申请日:2018-04-25
Applicant: The University of Chicago
Inventor: Marcus R. Clark , Maryellen L. Giger , Vladimir M. Liarski , Adam Sibley
Abstract: A method of analyzing cell populations includes receiving, by a transceiver of a computing device, an image of a tissue sample. The method also includes analyzing, by a processor of the computing device, the image of the tissue sample using image analysis. The image analysis parameters are determined by machine learning. The method also includes determining, by the processor and based on the analyzing, one or more cell features, such as shape, of a cell in the tissue sample. The method further includes identifying, by the processor, an interaction of the cell with an additional cell based at least in part on the shape of the cell.
-
公开(公告)号:US11461847B2
公开(公告)日:2022-10-04
申请号:US16826000
申请日:2020-03-20
Inventor: Dacheng Xiu , Zheng Tracy Ke , Bryan Kelly
Abstract: Systems, methods, and computer-readable storage media facilitating automated testing of datasets including natural language data are disclosed. In the disclosed embodiments, rule sets may be used to condition and transform an input dataset into a format that is suitable for use with one or more artificial intelligence processes configured to extract parameters and classification information from the input dataset. The parameters and classes derived by the artificial intelligence processes may then be used to automatically generate various testing tools (e.g., scripts, test conditions, etc.) that may be executed against a test dataset, such as program code or other types of data.
-
公开(公告)号:US11459400B2
公开(公告)日:2022-10-04
申请号:US15745496
申请日:2016-07-15
Applicant: The University of Chicago
Inventor: Shohei Koide , Shun-Ichi Tanaka , Akiko Koide
IPC: G01N33/53 , G01N33/569 , G01N33/573 , C07K16/40 , C12Q1/26 , C12Q1/34 , C12Q1/48 , C12Q1/527 , C12Q1/533 , C12Q1/00 , C12N9/38 , C07K14/78 , C12N9/20 , C12Q1/25 , G01N33/58 , G01N33/60
Abstract: Aspects of the disclosure relate to compositions of enzyme-binding polypeptides (EBPs) that modify the substrate specificity of an enzyme and a method for identifying an EBP that modifies substrate specificity of an enzyme binding at least one substrate, the method comprising: contacting the enzyme with a polypeptide library comprising a plurality of EBPs that bind different epitopes of the enzyme; identifying EBPs that bind to the enzyme to form an EBP-enzyme complex; assaying for the activity level and substrate specificity of the EBP-enzyme complex; and identifying EBPs that modify the substrate specificity of the enzyme by identifying EBPs that, when in an EBP-enzyme complex, have a different substrate specificity than un-complexed EBP; wherein the catalytic rate constant of the EBP-enzyme complex is ≥50% of the un-complexed enzyme for at least one substrate and/or wherein the EBP-enzyme complex retains binding to a substrate.
-
公开(公告)号:US20220296656A1
公开(公告)日:2022-09-22
申请号:US17517084
申请日:2021-11-02
Applicant: The University of Chicago
Inventor: Thomas F. Gajewski , Ayelet Sivan , Leticia Corrales
IPC: A61K35/741 , A61K45/06 , A61K9/00 , A61K35/742 , A61K35/745 , A61K35/747 , A61K39/395 , C07K16/28
Abstract: Provided herein are methods of treatment and/or prevention of cancer by manipulation of commensal microflora. In particular, the amount, identity, presence, and/or ratio of microflora (e.g., gut microflora) in a subject is manipulated to facilitate one or more co-treatments.
-
公开(公告)号:US20220291450A1
公开(公告)日:2022-09-15
申请号:US17635088
申请日:2020-08-14
Applicant: THE UNIVERSITY OF CHICAGO
Inventor: Tian ZHONG , Christina WICKER
Abstract: Technologies for a strong rare-earth-ion interactions are disclosed. In the illustrative embodiment, a heterogeneous slot waveguide is formed with two layers of silicon surrounding a layer of Er:Y2O3, resulting in a waveguide that supports a TM mode with a strong confinement of electromagnetic field near the erbium dopants. The strong concentration of electromagnetic field and small mode volume allows for strong interactions between optical fields and the erbium dopants. In some embodiments, the slot waveguide structure may be configured as a microring resonator or a photonic crystal, resulting in small-mode-volume resonators with high Q-factors. In some embodiments, strong electro-optic and/or acousto-optic coupling may be achieved, resulting in quantum transducer able to coherently convert between signals in different systems.
-
公开(公告)号:US20220281936A1
公开(公告)日:2022-09-08
申请号:US17597793
申请日:2020-07-24
Applicant: The University of Chicago
Inventor: Jeffrey HUBBELL , Jun ISHIHARA , Juan MENDOZA , Aslan MANSUROV
IPC: C07K14/54 , C07K14/715 , A61K47/68 , A61K39/395 , A61P35/00
Abstract: he disclosure relates to the engineering of collagen-binding modification of masked therapeutic agents comprising one or more tumor-associated protease cleavage sites. Upon exposure to tumor-associated proteases in the tumor microenvironment, the polypeptide is cleaved, which unmasks the therapeutic agent, reducing off-target side effects and toxicity associated with systemic administration. Accordingly, aspects of the disclosure relate to a polypeptide comprising a therapeutic agent linked to a masking agent through a linker, wherein the linker comprises one or more tumor-associated protease cleavage sites, and wherein the masking agent blocks the association of the therapeutic agent to its therapeutic target, and further wherein the polypeptide is operatively linked to a collagen binding domain or a tumor-targeting agent.
-
公开(公告)号:US20220227819A1
公开(公告)日:2022-07-21
申请号:US17645344
申请日:2021-12-21
Applicant: The University of Chicago , Janssen Pharmaceuticals, Inc.
Inventor: Dominique Missiakas , Olaf Schneewind , Carla Emolo , Lena Thomer , Molly McAdow , Jeroen Geurtsen , Mark De Been
Abstract: Embodiments concern methods and compositions for treating or preventing a bacterial infection, particularly infection by a Staphylococcus bacterium. Aspects include methods and compositions for providing a passive immune response against the bacteria. In certain embodiments, the methods and compositions involve an antibody that binds Coagulase (Coa). Further aspects relate to immunogenic compositions comprising at least one Staphylococcal coagulase R Domain, wherein the R Domain is 80% identical in sequence to a R Domain.
-
-
-
-
-
-
-
-
-